## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STNβDBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv
Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease
β Scribed by Casey H. Halpern; Jacqueline H. Rick; Shabbar F. Danish; Murray Grossman; Gordon H. Baltuch
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 95 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2149
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
Parkinson's disease (PD) is a neurodegenerative disorder characterized by significant motor dysfunction and various nonβmotor disturbances, including cognitive alterations. Deep brain stimulation (DBS) is an increasingly utilized therapeutic option for patients with PD that yields remarkable success in alleviating disabling motor symptoms. DBS has additionally been associated with changes in cognition, yet the evidence is not consistent across studies. The following review sought to provide a clearer understanding of the various cognitive sequelae of bilateral subthalamic nucleus (STN) DBS while taking into account corresponding neuroanatomy and potential confounding variables.
Design
A literature search was performed using the following inclusion criteria: (1) at least five subjects followed for a mean of at least 3 months after surgery; (2) preβ and postoperative cognitive data using at least one standardized measure; (3) adequate report of study results using means and standard deviations.
Results
Two recent metaβanalyses found mild postβoperative impairments in verbal learning and executive function in patients who underwent DBS surgery. However, studies have revealed improved working memory and psychomotor speed in the βonβ vs βoffβ stimulation state. A deficit in language may be a consequence of the surgical procedure.
Conclusions
While cognitive decline has been observed in some domains, our review of the data suggests that STN DBS is a worthwhile and safe method to treat PD. Copyright Β© 2008 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Camptocormia becomes increasingly recognized as a disabling symptom associated with Parkinson's disease (PD). We here report six patients with advanced PD in whom continuous bilateral stimulation of the subthalamic nucleus produced substantial (mean 78% Β± 9.1% of the thoracolumbar angle
Deep brain stimulation of the subthalamic nucleus is an accepted treatment for the motor complications of Parkinson's disease. The therapeutic mechanism of action remains incompletely understood. Although the results of deep brain stimulation are similar to the results that can be obtained by lesion
## Abstract In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering fro
## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a treatment option for patients with Parkinson's disease (PD) in the advanced stage. Besides motor improvement, DBS of the STN may also modulate cognitive and attentional functions of the basal ganglia. In our study, 13 pa